Want to join the conversation?
JP Morgan analyst Chris Schott questions $MYL about the concerns its smaller competitors are experiencing that could impact its franchise. $MYL says that with respect to US Generics, the weakness experienced by smaller players is from niche product as well as how they were playing their business and positioning it.
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)
$AGIO plunge 15%.. what's happening... is this going for a toss !